Concord Biotech Limited

Stocks

Market Closed - NSE India S.E. Other stock markets 04:35:07 10/07/2026 pm IST			5-day change	1st Jan Change
1,304.70 ^INR	-0.05%		+2.34%	-3.04%

20/06	Fsge Renewable Power Private Limited announced that it expects to receive INR 63 million in funding from Concord Biotech Limited	CI
12/06	Brazilian Regulator Completes Inspection of Concord Biotech's Limbasi Facility	MT

Published on 02/12/2026 at 10:36 pm IST - Modified on 02/23/2026 at 10:38 pm IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, good day, and welcome to the Q3 and 9 Months FY '26 Earnings Conference Call of Concord Biotech Limited hosted by Antique

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

20/06	Fsge Renewable Power Private Limited announced that it expects to receive INR 63 million in funding from Concord Biotech Limited	CI
12/06	Brazilian Regulator Completes Inspection of Concord Biotech's Limbasi Facility	MT
10/06	Concord Biotech Gets US FDA Nod for Arthritis Treatment Drug; Shares Up 4%	MT
02/06	Choice Equity Downgrades Concord Biotech to Reduce from Add; Price Target is INR1,045	MT
02/06	Jefferies Adjusts Concord Biotech's Price Target to INR1,020 From INR1,170, Keeps at Hold	MT
01/06	Concord Biotech Limited, Q4 2026 Earnings Call, Jun 01, 2026
29/05	Concord Biotech Limited announces Annual dividend, payable on August 30, 2026	CI
29/05	Concord Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02/04	Concord Biotech Limited completed the acquisition of Celliimune Biotech Private Limited for 6.6 million.	CI
13/02	Jefferies Adjusts Concord Biotech's Price Target to INR1,170 From INR1,290, Keeps at Hold	MT
12/02	Concord Biotech Limited, Q3 2026 Earnings Call, Feb 12, 2026
11/02	Concord Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11/02	Concord Biotech Dec-quarter consol net profit 644.8 million rupees	RE
11/02	Concord Biotech Limited Appoints Paritosh Trivedi as Company Secretary, Compliance Officer, Effective February 11, 2026	CI
24/12	Concord Biotech Limited Announces Resignation of Hina Patel as Company Secretary and Compliance Officer, Effective January 21, 2026	CI